|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| G01N 33/53 | (2006.01) | ||
| C12N 15/13 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 2390267 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11002906.3 |
| Date of filing the European patent application | 2006-06-06 | |
| (97) | Date of publication of the European application | 2011-11-30 |
| (45) | Date of publication and mention of the grant of the patent | 2013-06-05 |
| (46) | Date of publication of the claims translation | 2013-08-26 |
| (30) | Number | Date | Country code |
| 687971 P | 2005-06-07 | US | |
| 785353 P | 2006-03-23 | US |
| (72) |
Ewert, Stefan, CH
Urech, David, CH
Lichtlen, Peter, CH
Barberis, Alcide, CH
Auf der Maur, Adrian, CH
|
| (73) |
ESBATech - a Novartis Company LLC,
Wagistrasse 21, 8952 Schlieren,
CH
|
| (74) |
Irena Milda SRĖBALIENĖ,
Patentinių paslaugų centras, UAB, J. Basanavičiaus g. 11/1, LT-03108 Vilnius,
LT
|
| (54) | Stabilūs ir tirpūs antikūnai, slopinantys TNF(alfa) |
| Stable and soluble antibodies inhibiting TNF(alpha) |
| Payment date | Validity (years) | Amount | |
| 2017-05-30 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-06-06 |